Trilo Therapeutics Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Trilo Therapeutics is a seed-stage biotechnology company based in San Francisco, California. It focuses on discovering advanced antibody-drug conjugates and peptide-drug conjugates for oncology, aiming to deliver highly potent chemotherapy or radiotherapy directly to tumor cells while enabling rapid clearance from the body to reduce toxicity. The company targets cancer researchers and development programs seeking next-generation conjugates that can penetrate tumors quickly and saturate malignant cells. Operating within the biotechnology research sector, Trilo Therapeutics situates itself among firms pursuing innovative targeted therapies, positioned as a small, early-stage player in the oncology drug discovery ecosystem.